Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2012

01-08-2012 | Original Article

Performance of the Fecal Immunochemical Test Is Not Decreased by High Ambient Temperature in the Rapid Return System

Authors: Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jae Jun Park, Jung Won Jeun, Jun Uk Lim, Sang-Hyun Hwang

Published in: Digestive Diseases and Sciences | Issue 8/2012

Login to get access

Abstract

Background

Hemoglobin concentration of fecal immunochemical test may be decreased at high ambient temperature, and fecal samples in FIT may be exposed to high ambient temperature.

Aims

The aim of this study was to determine whether a high ambient temperature on the day of screening may decrease the performance of FITs in population-based screening.

Methods

We performed FITs for asymptomatic participants aged 50 years or older. Fecal hemoglobin concentration, the probability of a positive FIT and a detection rate of colorectal neoplasms were compared between low (<10.0 °C) and high (≥25.0 °C) temperature groups.

Results

The FIT results for 8,316 participants were analyzed. The mean log10 Hb concentration in the low temperature group was significantly higher than those in the high temperature group (0.36 vs. 0.25 ng/ml, p = 0.000). Regression analysis showed that an increase in temperature of 1 °C reduced the probability of a positive FIT by 3.1 %. However, we found no differences between the two groups in the FIT positive rate and detection rate of colorectal neoplasms. In multivariate analysis, high ambient temperature was not a significant risk factor for either the positive FIT result or the detection of colorectal neoplasms.

Conclusions

Potential instability of fecal hemoglobin at high ambient temperatures should be considered; however, its influence on performance of FIT may be attenuated by the short exposure time of fecal samples to high ambient temperature (i.e., rapid return system).
Literature
1.
go back to reference Choi KS, Jun JK, Lee HY, Hahm MI, Oh JH, Park EC. Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health. 2010;10:265.PubMedCrossRef Choi KS, Jun JK, Lee HY, Hahm MI, Oh JH, Park EC. Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health. 2010;10:265.PubMedCrossRef
2.
go back to reference Shim JI, Kim Y, Han MA, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat. 2010;42:191–198.PubMedCrossRef Shim JI, Kim Y, Han MA, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat. 2010;42:191–198.PubMedCrossRef
3.
go back to reference Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening of colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–1318.PubMedCrossRef Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening of colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–1318.PubMedCrossRef
4.
go back to reference Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.PubMedCrossRef Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.PubMedCrossRef
5.
go back to reference Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736–740.PubMedCrossRef Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736–740.PubMedCrossRef
6.
go back to reference Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371.PubMedCrossRef Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371.PubMedCrossRef
7.
go back to reference Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.PubMedCrossRef Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.PubMedCrossRef
8.
go back to reference Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.PubMedCrossRef Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.PubMedCrossRef
9.
go back to reference Jørgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32.PubMedCrossRef Jørgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32.PubMedCrossRef
10.
go back to reference Young GP, John DJ, Winawer SJ, Rozen P, WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood test for screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499–2507.PubMed Young GP, John DJ, Winawer SJ, Rozen P, WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood test for screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499–2507.PubMed
11.
go back to reference Young GP, Sinatra MA, John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem. 1996;42:1107–1108.PubMed Young GP, Sinatra MA, John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem. 1996;42:1107–1108.PubMed
12.
go back to reference Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005;100:2519–2525.PubMedCrossRef Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005;100:2519–2525.PubMedCrossRef
13.
go back to reference Grazzini G, Ventura L, Zappa M, et al. Influence of seasonal variation in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from Florence district. Gut. 2010;59:1511–1515.PubMedCrossRef Grazzini G, Ventura L, Zappa M, et al. Influence of seasonal variation in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from Florence district. Gut. 2010;59:1511–1515.PubMedCrossRef
14.
15.
go back to reference Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–1422.PubMedCrossRef Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–1422.PubMedCrossRef
16.
go back to reference Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005;20:278–282.PubMedCrossRef Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005;20:278–282.PubMedCrossRef
17.
go back to reference Fenocchi E, Martinez L, Tolve J, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 2006;15:384–390.PubMedCrossRef Fenocchi E, Martinez L, Tolve J, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 2006;15:384–390.PubMedCrossRef
18.
go back to reference Rubeca T, Rapi S, Confortini M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB gold and OC sensor assays in a consecutive prospective screening series. Int J Biol Markers. 2006;21:157–161.PubMed Rubeca T, Rapi S, Confortini M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB gold and OC sensor assays in a consecutive prospective screening series. Int J Biol Markers. 2006;21:157–161.PubMed
19.
go back to reference Grazzini G, Gastiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13:19–26.PubMedCrossRef Grazzini G, Gastiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13:19–26.PubMedCrossRef
20.
go back to reference Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat. 2005;37:20–23.PubMedCrossRef Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat. 2005;37:20–23.PubMedCrossRef
21.
go back to reference Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen. 2002;9:99–103.PubMedCrossRef Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen. 2002;9:99–103.PubMedCrossRef
22.
go back to reference Rennert G. Colorectal cancer screening: will global warming affect the accuracy of FIT testing? Gut. 2010;59:1451–1452.PubMedCrossRef Rennert G. Colorectal cancer screening: will global warming affect the accuracy of FIT testing? Gut. 2010;59:1451–1452.PubMedCrossRef
Metadata
Title
Performance of the Fecal Immunochemical Test Is Not Decreased by High Ambient Temperature in the Rapid Return System
Authors
Jae Myung Cha
Joung Il Lee
Kwang Ro Joo
Hyun Phil Shin
Jae Jun Park
Jung Won Jeun
Jun Uk Lim
Sang-Hyun Hwang
Publication date
01-08-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2139-y

Other articles of this Issue 8/2012

Digestive Diseases and Sciences 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.